Diabetes: Dapagliflozin: an insulin-independent, therapeutic option for type 2 diabetes mellitus

Comment

Carol Wilson. Nat Rev Endocrinol. 2010 Oct.

. 2010 Oct;6(10):531.

doi: 10.1038/nrendo.2010.134.

No abstract available

Comment on

Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial.
Ferrannini E, Ramos SJ, Salsali A, Tang W, List JF. Ferrannini E, et al. Diabetes Care. 2010 Oct;33(10):2217-24. doi: 10.2337/dc10-0612. Epub 2010 Jun 21. Diabetes Care. 2010. PMID: 20566676 Free PMC article. Clinical Trial.
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial.
Bailey CJ, Gross JL, Pieters A, Bastien A, List JF. Bailey CJ, et al. Lancet. 2010 Jun 26;375(9733):2223-33. doi: 10.1016/S0140-6736(10)60407-2. Lancet. 2010. PMID: 20609968 Clinical Trial.